IFAS - Range Cattle Research and Education Center, University of Florida, Ona, FL.
Eastern Oregon Agricultural Research Center, Oregon State University, Burns, OR.
J Anim Sci. 2020 May 1;98(5). doi: 10.1093/jas/skaa123.
A 2-yr study evaluated the growth and postvaccination immune response of beef calves born from heifers offered no supplementation or pre- and postpartum supplementation of sugarcane molasses + urea with or without methionine hydroxy analog (MHA). On day 0 of each year (57 ± 5 d prepartum), Brangus crossbred beef heifers (n = 36/yr; 20 to 22 mo of age) were stratified by their initial body weight (BW; 396 ± 24.1 kg) and body condition score (BCS; 5.6 ± 0.43) and randomly allocated into 1 of 12 bahiagrass (Paspalum notatum) pastures (3 heifers/pasture). Treatments were randomly assigned to pastures (4 pastures/treatment/yr) and consisted of no supplementation (NOSUP) and supplementation of sugarcane molasses + urea (7.2 kg of DM/heifer/wk) with (MOL+) or without (MOL-) fortification with 105 g/heifer/wk of MHA. Treatments were provided from 57 ± 5 d prepartum until 17 ± 5 d postpartum (day 0 to 74). On day 74, all heifer-calf pairs were combined and managed as a single group until the end of the breeding season (day 237). Calves were early weaned at 89 ± 5 d of age (day 147), limit-fed at 3.5% of BW (DM basis) in drylot until day 201, and vaccinated against respiratory disease pathogens on days 160 and 188. Prepartum BCS on day 44 did not differ (P = 0.26) between MOL+ and MOL- heifers but both groups had greater (P < 0.0001) BCS than NOSUP heifers. Plasma concentrations of l-methionine on day 44 were the greatest (P ≤ 0.04) for MOL+ heifers and did not differ (P = 0.40) between NOSUP vs. MOL- heifers. Calf birth BW did not differ (P = 0.13) among treatments. Calf average daily gain (ADG) from birth to day 201 did not differ (P ≥ 0.17) between MOL+ vs. MOL- calves, but both groups had greater (P ≤ 0.05) ADG from birth to day 201 than NOSUP calves. Calf postvaccination plasma concentrations of glucose, cortisol, and haptoglobin did not differ among treatments (P ≥ 0.13). However, plasma concentrations of IGF-1 on day 167 and the overall positive vaccine seroconversion did not differ (P ≥ 0.18) between MOL- and MOL+ calves, but both were greater (P ≤ 0.04) compared with NOSUP calves. Hence, maternal supplementation of sugarcane molasses + urea increased BCS at calving and offspring BW gain and response to vaccination against respiratory pathogens compared with no maternal supplementation. MHA inclusion into maternal supplements effectively increased maternal plasma l-methionine concentrations but did not enhance maternal BCS at calving and offspring growth and postvaccination immune response.
一项为期 2 年的研究评估了从未接受补充或产前和产后补充糖蜜+尿素的小母牛以及补充或不补充蛋氨酸羟基类似物(MHA)的小母牛所生的肉牛犊的生长和疫苗接种后免疫反应。每年的 0 天(产前 57 ± 5 天),布郎格斯杂交肉牛小母牛(n = 36/yr;20 至 22 月龄)根据其初始体重(BW;396 ± 24.1 kg)和体况评分(BCS;5.6 ± 0.43)进行分层,并随机分配到 12 个 1 个班牙草(Paspalum notatum)牧场(3 头小母牛/牧场)之一。处理随机分配到牧场(4 个牧场/处理/年),包括不补充(NOSUP)和补充糖蜜+尿素(7.2 公斤 DM/头/周)+或不(MOL-)强化 105 克/头/周的 MHA。从产前 57 ± 5 天开始补充至产后 17 ± 5 天(0 至 74 天)。在第 74 天,所有的母牛-小牛对被组合在一起,作为一个单一的群体进行管理,直到繁殖季节结束(第 237 天)。小牛在 89 ± 5 日龄(第 147 天)早期断奶,在干饲料中以 3.5%的 BW(DM 基础)限制喂养,直到第 201 天,并在第 160 天和第 188 天接种呼吸道疾病病原体疫苗。产前第 44 天的 MOL+和 MOL-小母牛的 M 型血氨基酸(BCS)没有差异(P = 0.26),但两组的 BCS 都高于 NOSUP 小母牛(P < 0.0001)。产前第 44 天的 MOL+小母牛的 L-蛋氨酸血浆浓度最高(P ≤ 0.04),而 NOSUP 小母牛与 MOL-小母牛之间的血浆浓度没有差异(P = 0.40)。小牛出生 BW 在处理之间没有差异(P = 0.13)。从出生到第 201 天的小牛平均日增重(ADG)在 MOL+与 MOL-小牛之间没有差异(P ≥ 0.17),但两组从出生到第 201 天的 ADG 都比 NOSUP 小牛大(P ≤ 0.05)。小牛接种疫苗后的血糖、皮质醇和触珠蛋白血浆浓度在处理之间没有差异(P ≥ 0.13)。然而,第 167 天的 IGF-1 血浆浓度和总体阳性疫苗血清转化率在 MOL-和 MOL+小牛之间没有差异(P ≥ 0.18),但与 NOSUP 小牛相比,这两组的 IGF-1 血浆浓度都更高(P ≤ 0.04)。因此,与不进行母体补充相比,糖蜜+尿素的母体补充增加了产犊时的 BCS 和后代 BW 增益以及对呼吸道病原体疫苗的反应。MHA 纳入母体补充剂可有效提高母体血浆 L-蛋氨酸浓度,但不能提高母体产犊时的 BCS 和后代的生长和接种疫苗后的免疫反应。